Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation.
Times cited: 21
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
New England Journal of Medicine.
Times cited: 417